Type 2 diabetes is one of the most common chronic diseases in the world. The probability of osteoporosis in these patients is much higher than that in non diabetes patients. In addition, the morbidity and mortality rate of diabetes combined with osteoporosis is extremely high, which seriously affects human life and health. Many studies have found that type 2 diabetes and osteoporosis have many common high risk factors and pathogenesis, but the correlation between their drug treatment is still controversial, which fails to give accurate reference value to clinical medication. Therefore, the author summarized the latest references in recent years through induction and analysis, and found that the relationship between the two drugs in drug treatment is very close. For example, some anti type 2 diabetes drugs can not only improve blood sugar level but also regulate bone balance, and some anti osteoporosis drugs have certain value in reducing blood sugar, but the relationship between the two drug treatment needs further research and exploration. Here, the author discusses the correlation between the drug treatment of type 2 diabetes and osteoporosis, and makes a review, hoping to provide some reference value for clinical treatment. |